GlobeNewswire Inc | Sep 2, 2021 04:05PM EDT

September 02, 2021

FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB) today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

Cyteks management is scheduled to present on Tuesday, September 14th, at 2:00 p.m. Pacific Time/5:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the Investors section of the company website at: investors.cytekbio.com

About Cytek Biosciences

Cytek Biosciences is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Cyteks novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with exquisite sensitivity. Cyteks FSP platform includes its core instruments, the Aurora and Northern Lights systems, its cell sorter, the Aurora CS, and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe.

Other than Cyteks Northern Lights CLC system, which is available for clinical use in China and the European Union, Cyteks products are for research use only not for use in diagnostic procedures or for clinical purposes.

Cytek, Full Spectrum Profiling, FSP and Northern Lights are trademarks or registered trademarks of Cytek Biosciences, Inc.

Investor Relations Contact:Carrie Mendivil/Mary Kate McDonoughGilmartin Group LLC(518) 727-6380investors@cytekbio.com

Media Contact:Stephanie OlsenLages & Associates(949) 453-8080stephanie@lages.com